Jubbonti
Payments companies reported to CMS as associated with Jubbonti. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Jubbonti, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Jubbonti
These are the largest totals companies reported as associated with Jubbonti. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Raphael Kieval | Brockton, MA | Rheumatology | $177.01 |
| Sachin Gupta | Fresno, CA | Hematology & Oncology | $122.62 |
| David Theis | Colorado Springs, CO | Rheumatology | $93.96 |
| Robert Gelfand | New York, NY | Hematology & Oncology | $88.28 |
| Ileana Antoniadis | Spring Lake Heights, NJ | Rheumatology | $82.49 |
| Aastyn Guarino | Lansing, MI | Medical | $78.21 |
| Marie Sighe-Nzokou | Lansing, MI | Primary Care | $78.19 |
| Kevin Duffy | Lansing, MI | Physician Assistant | $78.19 |
| Barbara Slusher | Manning, SC | Physician Assistant | $77.74 |
| Jon Docherty | Florence, SC | Rheumatology | $77.72 |
Prescribed Jubbonti?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.